Economic Impact of Using an Immunostimulating Agent to Prevent Severe Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease

RATIONALE: OM-85 BV, an immunostimulant made from bacterial extracts, has been shown to reduce the risk of hospitalization for acute exacerbation in patients with chronic obstructive pulmonary disease, as well as to reduce the length of stay for all hospitalizations.

Bibliographic Details
Main Authors: Jean-Paul Collet, Thierry Ducruet, Seema Haider, Stan Shapiro, Ann Robinson, Paolo M Renzi, André-Pierre Contandriopoulos, Pierre Ernst
Format: Article
Language:English
Published: Hindawi Limited 2001-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2001/508015